Document Detail

Effects of transdermal 17beta-estradiol on left ventricular anatomy and performance in hypertensive women.
MedLine Citation:
PMID:  10567179     Owner:  NLM     Status:  MEDLINE    
To reduce cardiovascular complications, antihypertensive therapy should not only normalize blood pressure but also induce a regression of structural abnormalities, which are the expression of end-organ damage. We investigated the effects of transdermal 17beta-estradiol, combined with standard antihypertensive therapy, on the modification of left ventricular anatomy and systolic performance in hypertensive postmenopausal women. In a randomized, double-blind, placebo-controlled study, we enrolled 169 postmenopausal women with mild or moderate hypertension. Eighty-six patients (group 1) received transdermal 17beta-estradiol (50 microg/d) and norethisterone acetate (2.5 mg/d, orally), and 83 patients (group 2) received placebo. At baseline, all women underwent M-mode and 2-D echocardiogram, which was repeated after 6, 12, and 18 months of follow-up. After 18 months of treatment, we observed a significant decrease in left ventricular diastolic septal and posterior wall thickness and mass in both groups. Furthermore, after 18 months, left ventricular mass was significantly less than in the estrogen-treated group. No significant modifications were observed in left ventricular systolic and diastolic dimensions or in systolic performance, as expressed by left ventricular fractional shortening. In conclusion, transdermal 17beta-estradiol, which is associated with antihypertensive therapy, may contribute in the reduction of left ventricular mass in hypertensive postmenopausal women.
M G Modena; N Muia; P Aveta; R Molinari; R Rossi
Related Documents :
10889139 - Reverse remodeling of cardiac myocyte hypertrophy in hypertension and failure by target...
2572609 - Regression of left ventricular hypertrophy in treated hypertensive patients with dileva...
1535539 - Exercise blood pressure and echocardiographic abnormalities in genetically comparable p...
11810209 - Conservation of l-type ca2+ current characteristics in endo- and epicardial myocytes fr...
8087939 - Rapid two-stage arterial switch operation. acquisition of left ventricular mass after p...
3742749 - Septal geometry in the unloaded living human heart.
1125629 - Surgery of violence. v. missile wounds of the head and spine.
21929449 - Screening of a population at risk of chronic kidney disease: analysis of factors associ...
1328939 - Blood pressure during the interdialytic period in haemodialysis patients: estimation of...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Hypertension     Volume:  34     ISSN:  1524-4563     ISO Abbreviation:  Hypertension     Publication Date:  1999 Nov 
Date Detail:
Created Date:  1999-12-10     Completed Date:  1999-12-10     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7906255     Medline TA:  Hypertension     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1041-6     Citation Subset:  IM    
Institute of Cardiology II, Department of Internal Medicine, University of Modena, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Administration, Cutaneous
Double-Blind Method
Estradiol / administration & dosage*
Estrogen Replacement Therapy*
Hypertension / drug therapy*
Hypertrophy, Left Ventricular / prevention & control*
Middle Aged
Ventricular Function, Left / drug effects
Reg. No./Substance:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Ambulatory blood pressure and metabolic abnormalities in hypertensive subjects with inappropriately ...
Next Document:  Plasma leptin level is associated with myocardial wall thickness in hypertensive insulin-resistant m...